These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12604663)

  • 21. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
    León R; Garcia AG; Marco-Contelles J
    Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development of new therapeutics for Alzheimer's disease.
    Carter MD; Simms GA; Weaver DF
    Clin Pharmacol Ther; 2010 Oct; 88(4):475-86. PubMed ID: 20811351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular targeted therapy in Alzheimer disease].
    Morohashi Y; Tomita T; Iwatsubo T
    Nihon Rinsho; 2010 Oct; 68(10):1906-10. PubMed ID: 20954338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease.
    Bachurin SO
    Med Res Rev; 2003 Jan; 23(1):48-88. PubMed ID: 12424753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel insights for the treatment of Alzheimer's disease.
    Kurz A; Perneczky R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of new drugs for Alzheimer's disease].
    Tabira T
    Brain Nerve; 2010 Jul; 62(7):787-96. PubMed ID: 20675883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application.
    Pietrzik C; Behl C
    Int J Exp Pathol; 2005 Jun; 86(3):173-85. PubMed ID: 15910551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting amyloid precursor protein secretases: Alzheimer's disease and beyond.
    Ganjei JK
    Drug News Perspect; 2010 Nov; 23(9):573-84. PubMed ID: 21152452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current therapeutic strategy in Alzheimer's disease.
    Singh S; Kushwah AS; Singh R; Farswan M; Kaur R
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1651-64. PubMed ID: 23161037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
    Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
    Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigational medications for treatment of patients with Alzheimer disease.
    Potter PE
    J Am Osteopath Assoc; 2010 Sep; 110(9 Suppl 8):S27-36. PubMed ID: 20926740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of regeneration in Alzheimer's disease brain.
    Uchida Y
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S158-68. PubMed ID: 20590831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why as a medicinal chemist I am not optimistic about the possibility of finding, in a reasonable timeframe, small-molecule drugs capable of curing the evolution of Alzheimer's disease.
    Kraus JL
    ChemMedChem; 2012 Mar; 7(3):357-8. PubMed ID: 21990179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aβ regulation-based multitarget strategy for drug discovery against Alzheimer's disease.
    Guo X; Jiang W; Li C; Zhu Z; Shen X
    Rev Neurosci; 2015; 26(1):13-30. PubMed ID: 25720054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
    Thakral S; Yadav A; Singh V; Kumar M; Kumar P; Narang R; Sudhakar K; Verma A; Khalilullah H; Jaremko M; Emwas AH
    Ageing Res Rev; 2023 Jul; 88():101960. PubMed ID: 37224884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobiological aspects of Alzheimer's disease.
    Chopra K; Misra S; Kuhad A
    Expert Opin Ther Targets; 2011 May; 15(5):535-55. PubMed ID: 21314231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.